Customer Testimonials
As a nurse leader, my role is to support my staff by ensuring they have products that improve patient care and make their jobs easier. The Steripath® ISDD® is a perfect example – it is a powerful tool in our mission to Zero Harm and doesn’t slow down the clinicians. We decreased blood culture contaminations in our Emergency Department by 94%, down to 0.22%, using Steripath.
While the nursing team made this possible, it was the clinical team at Magnolia Medical that made my dream a reality. Their availability, knowledge, and patience with our team as they developed a new skill was remarkable. They helped me develop an implementation and a sustainment plan. Over the past three years, they have been at my side to ensure that patient safety as it relates to blood cultures remains a top priority. We continue to deliver Zero Harm care to our patients with Magnolia Medical Technologies and their Steripath device as our partners.
“
Carleen Merola, DNP, RN, TCRN, PCCN
Nurse Manager
Baylor White & Scott - Centennial
The initial allure of the Steripath® Initial Specimen Diversion Device® was its proven ability to reduce blood culture contamination. However, during the implementation phase, we discovered that the device’s quantitative effectiveness was paralleled by Magnolia Medical’s qualitative excellence. Magnolia Medical has continued to share in our commitment to success.
Their level of engagement throughout our ongoing project demonstrated that they take pride in their products as well as their clinical expertise, leveraging both to take hospitals to the next level with respect to best practices in blood culture collection. Other institutions considering adopting Steripath should be confident that they will be partnering with a company that has a vested interest in optimizing success for all stakeholders.
“
Todd M. Lasco, Ph.D., D(ABMM)
Assistant Professor, Baylor College of Medicine
Scientific Director, Microbiology, Immunology & Molecular Pathology
Steripath® ISDD® empowered Opelousas General Health System to achieve unexpected success in reaching the unprecedented goal of a blood culture contamination rate of <1% only 3 months after implementation.
“
Jerry Besson MS, BB(ASCP), CLS(LSBME)
Manager of Laboratory Services
When looking to improve patient outcomes and opportunities around decreasing contamination rates it was obvious that Steripath® ISDD® was the product that best aligned with my vision for success.
The company’s sales and clinical team displayed the knowledge, professionalism, and customer service confirming that I had made the right choice for a partner. I had an instant connection with them because we seemed to share the same uncompromising drive for excellence.
They adapted to the education model set for our department, which contributed significantly to our success. Implementing Steripath in our Emergency Department for both our adult and pediatric population resulted in an immediate decrease in our contamination rate to 0%!
I am very proud of the lives we have impacted through this product. The entire process was seamless. The staff engagement was infectious. The consistent, continued results speak volume!
“
Ashley Guillory, BSN, RN
Director, Emergency Services
Our Lady of Lourdes Women’s & Children’s Hospital
Reducing our blood culture contamination rate has been a perpetual struggle. We made the decision to implement Steripath® ISDD® and saw remarkable results the very next month, achieving our goal of less than 1% in only two months.
The Magnolia Medical team has been with us every step of the way, providing needed resources and support to ensure a smooth and seamless transition of clinical practice for our ER team. Their knowledge and hands-on training made the difference for our team.
“
Debby York, BSN, RN
Regional Director, Emergency Room
Baylor Scott & White
Time and time again, Steripath® ISDD® has been shown to be an amazing solution to deliver sustained reduction in contamination rates below 1%.
I am a big fan. Steripath is an extremely cost-effective and elegantly engineered solution to a problem that has existed for decades. We are seeing actual results that prevent patient harm and directly drive antibiotic stewardship.
“
Shanise Keith, NCPT(NHA)
Director
Center for Phlebotomy Education
Phlebotomy Today
The Phlebotomy Channel
As a human-factor engineered device, Steripath® ISDD® can dramatically reduce blood culture contamination and has clearly demonstrated that getting to 0.0% is achievable.
As a result of our experience with the Steripath platform, we join others in the national movement to establish a goal of 0.0% blood culture contamination starting with a new standard benchmark of less than 1.0% as the new standard of care.
“
Lucy Tompkins, MD, PhD
Professor, Infectious Diseases and Microbiology
Hospital Epidemiologist
Medical Director, Infection Prevention and Control
Stanford University Hospital
Steripath® ISDD® supports two of our strategic pillars in providing high quality care – diagnostic stewardship and antimicrobial stewardship. With Steripath and Magnolia Medical’s industry-leading practice change process, we have sustained contamination rates well below the 2022 CLSI goal of 1%.
“
Jason Betts, DNP, RN, CEN
Director, Emergency Services
Emory Decatur Hospital
Our collective vision to surpass the accepted norm for blood culture contamination rates began with Steripath® ISDD® after previous interventions, including training & education and device interventions, failed to sustain contamination rates below 3%.
With Steripath, we achieved a sustained hospital-wide reduction in contamination rates of 81% and have promoted a process through objective study that endorses Steripath for blood culture collection and contamination prevention across WVU Medicine facilities.
“
Mark D. Povroznik, PharmD
VP, Quality and Safety / Chief Quality Officer
Chairman, Infection Control
Chairman, System Infection Control Affinity
The adoption of Steripath® ISDD® is the easiest solution to directly, immediately and significantly drive antibiotic stewardship and reduce false-positive CLABSIs”
“
Barbara DeBaun, RN, MSN, CIC
Improvement Advisor for Cynosure Health Former Director, Patient Safety and Infection Control California Pacific Medical Center, San Francisco